Patricia A. Cleary

18.1k total citations · 3 hit papers
148 papers, 12.0k citations indexed

About

Patricia A. Cleary is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Patricia A. Cleary has authored 148 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Cardiology and Cardiovascular Medicine and 24 papers in Surgery. Recurrent topics in Patricia A. Cleary's work include Diabetes Management and Research (44 papers), Diabetes Treatment and Management (21 papers) and Diabetes and associated disorders (20 papers). Patricia A. Cleary is often cited by papers focused on Diabetes Management and Research (44 papers), Diabetes Treatment and Management (21 papers) and Diabetes and associated disorders (20 papers). Patricia A. Cleary collaborates with scholars based in United States, Canada and Israel. Patricia A. Cleary's co-authors include Leonard R. Derogatis, John M. Lachin, Roy W. Beck, Saul Genuth, Wanjie Sun, Michael W. Steffes, James W. Albers, Eva L. Feldman, Jye‐Yu C. Backlund and William T. Dahms and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Patricia A. Cleary

147 papers receiving 11.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Confirmation of the dimensional structure of the scl-90: A study in construct validation

1977 1.3k citations Patricia A. Cleary et al. profile →
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis

1992 849 citations Roy W. Beck, Patricia A. Cleary et al. profile →
Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality

2015 303 citations Trevor J. Orchard, David M. Nathan et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia A. Cleary United States	54	4.3k	1.8k	1.5k	1.5k	1.5k	148	12.0k
Thera P. Links Netherlands	53	5.3k 1.2×	2.2k 1.2×	1.0k 0.7×	641 0.4×	711 0.5×	277	10.4k
Francesco Chiarelli Italy	63	4.4k 1.0×	2.4k 1.3×	423 0.3×	563 0.4×	2.7k 1.8×	629	15.9k
Guðný Eiríksdóttir Iceland	58	1.6k 0.4×	2.4k 1.3×	792 0.5×	921 0.6×	970 0.6×	199	13.3k
Joyce A. Cramer United States	74	1.7k 0.4×	817 0.4×	935 0.6×	716 0.5×	828 0.6×	225	22.4k
Martin den Heijer Netherlands	64	1.9k 0.4×	2.5k 1.4×	340 0.2×	705 0.5×	1.5k 1.0×	371	16.2k
Alberto Verrotti Italy	54	1.3k 0.3×	896 0.5×	525 0.3×	411 0.3×	1.4k 0.9×	527	11.8k
Braxton D. Mitchell United States	67	4.8k 1.1×	3.0k 1.6×	457 0.3×	615 0.4×	3.3k 2.2×	375	18.3k
Peter H. Sönksen United Kingdom	52	7.1k 1.7×	1.1k 0.6×	762 0.5×	252 0.2×	1.2k 0.8×	222	10.7k
Daniel R. Witte Denmark	55	3.9k 0.9×	1.6k 0.9×	851 0.6×	294 0.2×	1.3k 0.9×	229	10.8k
Peter J. Grant United Kingdom	67	3.4k 0.8×	1.6k 0.9×	412 0.3×	273 0.2×	858 0.6×	267	14.6k

Countries citing papers authored by Patricia A. Cleary

Since Specialization

Citations

This map shows the geographic impact of Patricia A. Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Cleary more than expected).

Fields of papers citing papers by Patricia A. Cleary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Cleary. The network helps show where Patricia A. Cleary may publish in the future.

Co-authorship network of co-authors of Patricia A. Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia A. Cleary. A scholar is included among the top collaborators of Patricia A. Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia A. Cleary. Patricia A. Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Catherine, Ionut Bebu, Barbara H. Braffett, et al.. (2015). Testosterone and cardiac mass and function in men with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC). Clinical Endocrinology. 84(5). 693–699. 6 indexed citations

Eny, Karen, Trevor J. Orchard, Rachel G. Miller, et al.. (2015). Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. Diabetes Technology & Therapeutics. 17(10). 726–734. 16 indexed citations

Orchard, Trevor J., David M. Nathan, Bernard Zinman, et al.. (2015). Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality. JAMA. 313(1). 45–45. 303 indexed citations breakdown →

Monnier, Vincent M., Wanjie Sun, Xiaoyu Gao, et al.. (2015). Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovascular Diabetology. 14(1). 118–118. 51 indexed citations

Bharucha, Adil E., Patricia A. Cleary, Joseph A. Murray, et al.. (2015). Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus. Gastroenterology. 149(2). 330–339. 100 indexed citations

Sarma, Aruna V., James M. Hotaling, Rodney L. Dunn, et al.. (2014). Poor Glycemic Control is Associated with Reduced Prostate Specific Antigen Concentrations in Men with Type 1 Diabetes. The Journal of Urology. 193(3). 786–793. 15 indexed citations

Cleary, Patricia A., Barbara H. Braffett, Trevor J. Orchard, et al.. (2013). Clinical and Technical Factors Associated with Skin Intrinsic Fluorescence in Subjects with Type 1 Diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Technology & Therapeutics. 15(6). 466–474. 42 indexed citations

Orchard, Trevor J., Wanjie Sun, Patricia A. Cleary, et al.. (2013). Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 3 indexed citations

Aiello, Lloyd, Wanjie Sun, Patricia A. Cleary, et al.. (2013). Intensive Diabetes Therapy Reduces Ocular Surgeries in Patients with Type 1 Diabetes: twenty-eight year followup of the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Investigative Ophthalmology & Visual Science. 54(15). 4024–4024. 2 indexed citations

10.

Polak, Joseph F., Jye‐Yu C. Backlund, Patricia A. Cleary, et al.. (2011). Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 60(2). 607–613. 101 indexed citations

11.

Hubbard, Larry D., et al.. (2010). Comparability of Digital vs. Film Grading of Diabetic Retinopathy Severity in DCCT/EDIC. Investigative Ophthalmology & Visual Science. 51(13). 4674–4674. 1 indexed citations

12.

Martin, Catherine L., Barbara H. Waberski, Rodica Pop‐Busui, et al.. (2010). Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes. Diabetes Care. 33(12). 2635–2641. 64 indexed citations

13.

Jacobson, A., Andrew D. Paterson, Christopher M. Ryan, et al.. (2009). The associations of apolipoprotein E and angiotensin‐converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18‐year follow‐up of the DCCT cohort. Diabetic Medicine. 27(1). 15–22. 12 indexed citations

14.

Martin, Catherine L., James W. Albers, William H. Herman, et al.. (2006). Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion. Diabetes Care. 29(2). 340–344. 246 indexed citations

15.

Mueller, Patricia W., John Rogus, Patricia A. Cleary, et al.. (2006). Genetics of Kidneys in Diabetes (GoKinD) Study. Journal of the American Society of Nephrology. 17(7). 1782–1790. 94 indexed citations

16.

Cornea, Anda, et al.. (2003). Neuroscience in Medicine. Humana Press eBooks. 13 indexed citations

17.

Steffes, Michael W., Mark E. Molitch, Blanche M. Chavers, Patricia A. Cleary, & John M. Lachin. (2003). Sustained effect of intensive treatment of type 1 diabetes mellitus on the development and progression of diabetic nephropathy in epidemiology of diabetes interventions and complications (EDIC) study.. JAMA. 290(16). 41 indexed citations

18.

Keltner, John L., et al.. (1993). Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT). Controlled Clinical Trials. 14(2). 143–159. 45 indexed citations

19.

Albers, J J, Scott M. Grundy, & Patricia A. Cleary. (1981). The national cooperative gallstone study: Effect of chenodeoxycholic acid on lipoproteins. Gastroenterology. 80. 1 indexed citations

20.

Petrie, William M., et al.. (1978). The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 22–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact